ORPHA:1344
Isolated atrial standstill
Also known as: Isolated atrial cardiomyopathy with heart block
Publications
350
65.4th percentile
Trials
0
Interventional, condition-specific
Researchers
1,207
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare cardiac rhythm disease characterized by a transient or permanent absence of electrical and mechanical atrial activity. Electrocardiographic findings include bradycardia, ectopic supraventricular rhythms, lack of atrial excitability and absent P waves.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0015281
- MeSH:C563984
- UMLS:C0541782
Additional Mondo synonyms (1)
atrial cardiomyopathy with heart block
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
350 matched papers (170 in last 10 years) Source
- Phenotype characterisedPresent
52 HPO annotations (e.g. Dyspnea; Muscular dystrophy; Arrhythmia) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
52
Associated phenotypes · MONDO:0015281
- Dyspnea
- Muscular dystrophy
- Arrhythmia
- Sick sinus syndrome
- Complete right bundle branch block
Showing 5 of 52 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
3 associated chemicals · 14 pathways. Therapeutic evidence is listed first when present — not a treatment recommendation.
- Atropine · therapeutic
- Isoproterenol · therapeutic
- Flecainide · marker/mechanism
Pathways: HIF-1 signaling pathway; Gap junction trafficking and regulation; Gap junction trafficking; Gap junction assembly; Membrane Trafficking; YAP1- and WWTR1 (TAZ)-stimulated gene expression; Generic Transcription Pathway; Metabolism of proteins
Literature
Is anyone studying this?
350
350 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
350 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
170 in the last 10 years · high confidence · 65.4th percentile (publications denominator)
Phrase hits: 350 · MeSH hits: 0
Who's working on it?
1,207
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Arbustini E7 papers · 2026
Centre for Inherited Cardiovascular Diseases, IRCCS Foundation, Policlinico San Matteo, Pavia, Italy.
Papers in Europe PMC - 02Lin Y6 papers · 2022
The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, 523710, Guangdong Province, China. linyubi88@qq.com.
Papers in Europe PMC - 03Marini M5 papers · 2026
Divisione di Cardiologia, Ospedale S. Chiara, Trento. marini_massimiliano@jumpy.it
Papers in Europe PMC - 04Wang J5 papers · 2026
Department of Cardiology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
Papers in Europe PMC - 05Makita N4 papers · 2022
Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan. makitan@med.hokudai.ac.jp
Papers in Europe PMC - 06Ravelli F4 papers · 2026
Department of Physics, University of Trento, Povo, Trento, Italy.
Papers in Europe PMC - 07Xie Y4 papers · 2026
Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Papers in Europe PMC - 08Bonmassari R3 papers · 2026
Department of Cardiology, Santa Chiara Hospital, 38122 Trento, Italy.
Papers in Europe PMC - 09Disertori M3 papers · 2014
Department of Cardiology, Santa Chiara Hospital, Trento, Italy.
Papers in Europe PMC - 10Li H3 papers · 2023
The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, 523710, Guangdong Province, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
high confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 20 · after dedupe 20 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 20 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (20)
- isrctn·ISRCTN57145331·No longer recruiting·The efficacy and mechanism of trientine in patients with hypertrophic cardiomyopathy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN29621851·No longer recruiting·Continuous selumetinib versus continuous or interrupted selumetinib in combination with weekly paclitaxel in metastatic uveal melanoma
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN60443207·Recruiting·Comparing three types of specialist pacemakers to improve heart function and reduce rhythm problems in heart failure
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN79322795·Recruiting·Sotagliflozin in patients with heart failure symptoms and type 1 diabetes
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN45965456·Suspended·Randomised, open-label international trial with Verapamil alone compared with Verapamil plus another immunotherapy for people with newly diagnosed type 1 diabetes
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN64700462·No longer recruiting·Mechanisms of excess risk in aortic stenosis after aortic valve replacement
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13837507·No longer recruiting·Assessing acute and late developing heart function in patients with sepsis and septic shock with cardiac ultrasound
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN96610559·No longer recruiting·Coenzyme Q10 supplementation in heart failure with preserved ejection fraction patients
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN82621856·No longer recruiting·Pacemaker therapy for drug-refractory symptoms in mid-cavity hypertrophic cardiomyopathy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN91621241·No longer recruiting·The PIROUETTE trial
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN95259705·No longer recruiting·Rate control therapy evaluation in atrial fibrillation
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN78539530·No longer recruiting·Rehabilitation enablement in chronic heart failure
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17309312·No longer recruiting·Isoprenaline infusion as a method of induction of atrial fibrillation
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN86234930·No longer recruiting·Rehabilitation Enablement in Chronic Heart Failure (REACH HF). A multicentre parallel group randomised controlled trial with parallel economic and process evaluation to assess the clinical effectiveness and cost-effectiveness of the REACH HF manual for patients and caregivers
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN66067800·No longer recruiting·Evaluation versus placebo of the effects on heart rate, haemodynamic parameters, safety and tolerability of 5 mg bolus of ivabradine followed by 8-hour infusion of 5 mg of ivabradine, given to patients undergoing a percutaneous coronary intervention following a myocardial infarction with ST segment elevation (STEMI): a pilot, blind, randomised, placebo-controlled, international, multi-centre study including the ancillary sub-study to the clinical study protocol
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13967269·No longer recruiting·BENznidazole Evaluation For Interrupting Trypanosomiasis pilot trial
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN45146526·No longer recruiting·Physical Counterpressure manoeuvre trial
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN78204941·No longer recruiting·BACE-PACE-Trial - A multicenter study to investigate preventive pacing in combination with antiarrhythmic beta-blocker or AT-I-/angiotensin converting enzyme (ACE)-inhibitor therapy on the recurrence of atrial fibrillation (AF) in patients with dual-chamber pacemakers
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN84858671·No longer recruiting·Atrial fibrillation and congestive heart failure (AF-CHF) study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN42560370·No longer recruiting·Evaluation of resynchronization therapy for heart failure (EARTH)
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Isolated atrial standstill — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Isolated atrial standstill" OR "Isolated atrial cardiomyopathy with heart block" OR "atrial cardiomyopathy with heart block"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Isolated atrial standstill" OR "Isolated atrial cardiomyopathy with heart block" OR "atrial cardiomyopathy with heart block"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T17:07:46.701Z
